These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 27748467)

  • 21. Replacement of implantable cardioverter defibrillators and cardiac resynchronization therapy devices: results of the European Heart Rhythm Association survey.
    Tilz R; Boveda S; Deharo JC; Dobreanu D; Haugaa KH; Dagres N
    Europace; 2016 Jun; 18(6):945-9. PubMed ID: 27297231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outcomes in pacemaker-dependent patients upgraded from conventional pacemakers to cardiac resynchronization therapy-defibrillators.
    Adelstein E; Schwartzman D; Bazaz R; Jain S; Gorcsan J; Saba S
    Heart Rhythm; 2014 Jun; 11(6):1008-14. PubMed ID: 24657426
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Implantable devices for management of chronic heart failure: defibrillators and biventricular pacing therapy.
    Pires LA
    Curr Opin Anaesthesiol; 2006 Feb; 19(1):69-74. PubMed ID: 16547436
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comprehensive multicomponent cardiac rehabilitation in cardiac implantable electronic devices recipients: a consensus document from the European Association of Preventive Cardiology (EAPC; Secondary prevention and rehabilitation section) and European Heart Rhythm Association (EHRA).
    Pedretti RFE; Iliou MC; Israel CW; Abreu A; Miljoen H; Corrà U; Stellbrink C; Gevaert AB; Theuns DA; Piepoli MF; Reibis R; Schmid JP; Wilhelm M; Heidbuchel H; Völler H; ; Ambrosetti M; Deneke T; Cornelissen V; R Heinzel F; Davos CH; Kudaiberdieva G; Frederix I; Svendsen JH; Hansen D
    Eur J Prev Cardiol; 2021 Dec; 28(15):1736-1752. PubMed ID: 34038513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of early comprehensive cardiac rehabilitation following the implantation of cardioverter-defibrillator.
    Śmiałek J; Lelakowski J; Majewski J
    Kardiol Pol; 2013; 71(10):1021-8. PubMed ID: 24197582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between biventricular pacing and cardiac resynchronization therapy-defibrillator efficacy when compared with implantable cardioverter defibrillator on outcomes and reverse remodelling.
    Ruwald AC; Kutyifa V; Ruwald MH; Solomon S; Daubert JP; Jons C; Brenyo A; McNitt S; Do D; Tanabe K; Al-Ahmad A; Wang P; Moss AJ; Zareba W
    Eur Heart J; 2015 Feb; 36(7):440-8. PubMed ID: 25112662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of cardiac resynchronization therapy with implantable cardioverter defibrillator versus cardiac resynchronization therapy with pacemaker on mortality in heart failure patients: results of a high-volume, single-centre experience.
    Kutyifa V; Geller L; Bogyi P; Zima E; Aktas MK; Ozcan EE; Becker D; Nagy VK; Kosztin A; Szilagyi S; Merkely B
    Eur J Heart Fail; 2014 Dec; 16(12):1323-30. PubMed ID: 25379962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Perioperative Sensor and Algorithm Programming in Patients with Implanted ICDs and Pacemakers for Cardiac Resynchronization Therapy.
    Niedermeier A; Vitali-Serdoz L; Fischlein T; Kirste W; Buia V; Walaschek J; Rittger H; Bastian D
    Sensors (Basel); 2021 Dec; 21(24):. PubMed ID: 34960440
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The Pacemaker and Implantable Cardioverter-Defibrillator Registry of the Italian Association of Arrhythmology and Cardiac Pacing - Annual report 2016].
    Proclemer A; Zecchin M; D'Onofrio A; Boriani G; Facchin D; Rebellato L; Ghidina M; Bianco G; Bernardelli E; Pucher E; Gregori D
    G Ital Cardiol (Rome); 2018 Feb; 19(2):119-131. PubMed ID: 29531385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complications of permanent cardiac pacing in patients with persistent left superior vena cava.
    Polewczyk A; Kutarski A; Czekajska-Chehab E; Adamczyk P; Boczar K; Polewczyk M; Janion M
    Cardiol J; 2014; 21(2):128-37. PubMed ID: 24526508
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Device therapy of chronic heart failure: Update 2015].
    Israel CW; Ekosso-Ejangue L; Sheta MK
    Herz; 2015 Dec; 40(8):1121-32; quiz 1133-4. PubMed ID: 26631395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Position paper for management of elderly patients with pacemakers and implantable cardiac defibrillators Groupe de rythmologie et stimulation cardiaque de la Société française de cardiologie et Société française de gériatrie et gérontologie.
    Fauchier L; Alonso C; Anselme F; Blangy H; Bordachar P; Boveda S; Clementy N; Defaye P; Deharo JC; Friocourt P; Gras D; Halimi F; Klug D; Mansourati J; Obadia B; Pasquié JL; Pavin D; Sadoul N; Taieb J; Piot O; Hanon O
    Geriatr Psychol Neuropsychiatr Vieil; 2016 Sep; 14(3):239-64. PubMed ID: 27651007
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pacemaker, implantable cardioverter defibrillator, CRT, CRT-D, psychological difficulties and quality of life.
    Calvagna GM; Torrisi G; Giuffrida C; Patanè S
    Int J Cardiol; 2014 Jun; 174(2):378-80. PubMed ID: 24794556
    [No Abstract]   [Full Text] [Related]  

  • 34. [Cardiac rehabilitation in LVAD patients : Aspects regarding exercise and rhythm].
    Schmidt T; Reiss N
    Herzschrittmacherther Elektrophysiol; 2023 Mar; 34(1):45-51. PubMed ID: 36580090
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization Therapy (MADIT-CRT) trial.
    Ruwald MH; Solomon SD; Foster E; Kutyifa V; Ruwald AC; Sherazi S; McNitt S; Jons C; Moss AJ; Zareba W
    Circulation; 2014 Dec; 130(25):2278-86. PubMed ID: 25301831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical effectiveness of cardiac resynchronization and implantable cardioverter-defibrillator therapy in men and women with heart failure: findings from IMPROVE HF.
    Wilcox JE; Fonarow GC; Zhang Y; Albert NM; Curtis AB; Gheorghiade M; Heywood JT; Mehra MR; O'Connor CM; Reynolds D; Walsh MN; Yancy CW
    Circ Heart Fail; 2014 Jan; 7(1):146-53. PubMed ID: 24178311
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Implantable cardioverter-defibrillator patients who are upgraded and respond to cardiac resynchronization therapy have less ventricular arrhythmias compared with nonresponders.
    Thijssen J; Borleffs CJ; Delgado V; van Rees JB; Mooyaart EA; van Bommel RJ; van Erven L; Boersma E; Bax JJ; Schalij MJ
    J Am Coll Cardiol; 2011 Nov; 58(22):2282-9. PubMed ID: 22093504
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Day by day telemetric care of patients treated with cardiac resynchronisation therapy: first Polish experience.
    Liberska A; Kowalski O; Mazurek M; Lenarczyk R; Jędrzejczyk-Patej E; Przybylska-Siedlecka K; Kozieł M; Morawski S; Podolecki T; Kowalczyk J; Pruszkowska P; Pluta S; Sokal A; Kalarus Z
    Kardiol Pol; 2016; 74(8):741-748. PubMed ID: 26898970
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive factors of lead failure in patients implanted with cardiac devices.
    Aizawa Y; Negishi M; Kashimura S; Nakajima K; Kunitomi A; Katsumata Y; Nishiyama T; Kimura T; Nishiyama N; Fukumoto K; Tanimoto Y; Kohsaka S; Takatsuki S; Fukuda K
    Int J Cardiol; 2015 Nov; 199():277-81. PubMed ID: 26218183
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Indications for pacemakers, implantable cardioverter-defibrillator and cardiac resynchronization devices.
    Samii SM
    Med Clin North Am; 2015 Jul; 99(4):795-804. PubMed ID: 26042883
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.